{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:21:09Z","timestamp":1788499269416,"version":"build-2803163510"},"reference-count":57,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: The majority of head and neck cancers (HNCs) occur in the larynx. In clinical practice, adverse effects are frequently observed in laryngeal cancer (LC) patients undergoing radiotherapy (RT). Therefore, investigating markers that can predict these unfavorable events is of interest. Long non-coding RNAs (lncRNAs) have emerged as potential biomarkers for the early identification of patients susceptible to post-RT toxicity. MALAT1 and NEAT1 regulate various cellular processes, the inflammatory response, and resistance to anti-cancer treatments; however, their impact on the portability of post-RT adverse effects remains unknown. The aim of this study was to evaluate the clinical value of two plasma-circulating lncRNAs, MALAT1 and NEAT1, as predictive biomarkers for post-RT adverse effects in LC patients. Methods: The expression levels of the studied lncRNAs were determined using real-time quantitative reverse transcription PCR (qRT-PCR) in plasma samples obtained from 70 LC patients before the initiation of RT. These levels were then correlated with patient outcomes. Results: A low expression of MALAT1 was associated with a significantly higher probability of anemia, liver failure, and severe malnutrition (OR = 5.36; p = 0.040, OR = 6.07; p = 0.037, OR = 9.75; p &lt; 0.001, respectively) after the completion of RT. Similarly, patients with low NEAT1 expression had a significantly higher risk of anemia, liver failure, and mild or severe malnutrition (OR = 5.26; p = 0.020, OR = 5.70; p = 0.016, OR = 13.09; p = 0.002, respectively). Simultaneous lower expression levels of both lncRNAs were significantly associated with shorter median overall survival (OS) in RT-treated LC patients (HR = 5.44; p = 0.001). Conclusions: The analysis of MALAT1 and NEAT1 expression indicates clinical utility in predicting toxic events induced by RT-based therapy.<\/jats:p>","DOI":"10.3390\/diagnostics15060676","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T09:36:24Z","timestamp":1741599384000},"page":"676","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Plasma Circulating lncRNAs: MALAT1 and NEAT1 as Biomarkers of Radiation-Induced Adverse Effects in Laryngeal Cancer Patients"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4040-0450","authenticated-orcid":false,"given":"Marcin","family":"Mazurek","sequence":"first","affiliation":[{"name":"Department of Human Physiology of Chair of Preclinical Sciences, Medical University of Lublin, 20-059 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Brzozowska","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, St. John of Dukla Lublin Region Cancer Center, 20-090 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Ma\u0142ecka-Massalska","sequence":"additional","affiliation":[{"name":"Department of Human Physiology of Chair of Preclinical Sciences, Medical University of Lublin, 20-059 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9174-8548","authenticated-orcid":false,"given":"Tomasz","family":"Powr\u00f3zek","sequence":"additional","affiliation":[{"name":"Department of Human Physiology of Chair of Preclinical Sciences, Medical University of Lublin, 20-059 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.oraloncology.2010.05.002","article-title":"Head and neck cancer in a developing country: A population-based perspective across 8years","volume":"46","author":"Attar","year":"2010","journal-title":"Oral Oncol."},{"key":"ref_2","first-page":"2248","article-title":"Laryngeal Cancer: Epidemiology, Etiology, and Prevention: A Narrative Review","volume":"52","author":"Igissin","year":"2023","journal-title":"Iran. J. Public Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1080\/01635581.2021.1952446","article-title":"Impact of Nutritional Status on Survival in Head and Neck Cancer Patients After Total Laryngectomy","volume":"74","author":"Santos","year":"2022","journal-title":"Nutr. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Takeuchi, T., Kawasaki, H., Luce, A., Cossu, A.M., Misso, G., Scrima, M., Bocchetti, M., Ricciardiello, F., Caraglia, M., and Zappavigna, S. (2020). Insight toward the MicroRNA Profiling of Laryngeal Cancers: Biological Role and Clinical Impact. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103693"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.currproblcancer.2016.06.001","article-title":"Toxicities associated with head and neck cancer treatment and oncology-related clinical trials","volume":"40","author":"Villa","year":"2016","journal-title":"Curr. Probl. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11547-015-0547-8","article-title":"Effectiveness of chemotherapy and radiotherapy for laryngeal preservation in advanced laryngeal cancer: A meta-analysis and systematic review","volume":"120","author":"Luo","year":"2015","journal-title":"Radiol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3857\/roj.2020.00213","article-title":"Late side effects of radiation treatment for head and neck cancer","volume":"38","author":"Brook","year":"2020","journal-title":"Radiat. Oncol. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1158\/2159-8290.CD-13-0197","article-title":"Radiogenomics: Using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy","volume":"4","author":"Kerns","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ijrobp.2011.04.022","article-title":"Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy","volume":"82","author":"Meyer","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Maahs, L., Ghanem, A.I., Gutta, R., Tang, A., Arya, S., Al Saheli, Z., Ali, H., Chang, S., Tam, S., and Wu, V. (2022). Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09708-9"},{"key":"ref_11","first-page":"877","article-title":"Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin","volume":"29","author":"Patimarattananan","year":"2021","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kong, L., and Birkeland, A.C. (2021). Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges. Cancers, 13.","DOI":"10.3390\/cancers13081874"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.gpb.2016.12.005","article-title":"Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA","volume":"15","author":"Dykes","year":"2017","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.rpor.2017.07.001","article-title":"Biological role of long non-coding RNA in head and neck cancers","volume":"22","author":"Kolenda","year":"2017","journal-title":"Reports Pract. Oncol. Radiother."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hahne, J.C., and Valeri, N. (2018). Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00226"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/modpathol.2012.160","article-title":"The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine","volume":"26","author":"Qi","year":"2013","journal-title":"Mod. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Xie, Y., Han, J., Xie, K., and Gou, Q. (2022). LncRNAs as biomarkers for predicting radioresistance and survival in cancer: A meta-analysis. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-21785-1"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"24850","DOI":"10.18632\/aging.203719","article-title":"Long noncoding RNA NEAT1 inhibits the acetylation of PTEN through the miR-524-5p \/HDAC1 axis to promote the proliferation and invasion of laryngeal cancer cells","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.21873\/anticanres.14235","article-title":"MALAT1 Decreases the Sensitivity of Head and Neck Squamous Cell Carcinoma Cells to Radiation and Cisplatin","volume":"40","author":"Kangboonruang","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10726","DOI":"10.18632\/oncotarget.12960","article-title":"Long noncoding RNAs in head and neck cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.oraloncology.2016.12.017","article-title":"A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma","volume":"65","author":"Cao","year":"2017","journal-title":"Oral Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hussein, M.A., Valinezhad, K., Adel, E., and Munirathinam, G. (2024). MALAT-1 Is a Key Regulator of Epithelial-Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis. Cancers, 16.","DOI":"10.3390\/cancers16010234"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.2147\/OTT.S317234","article-title":"The Role and Mechanism of MALAT1 Long Non-Coding RNA in the Diagnosis and Treatment of Head and Neck Squamous Cell Carcinoma","volume":"14","author":"Ye","year":"2021","journal-title":"Onco Targets. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9942880","DOI":"10.1155\/2023\/9942880","article-title":"Regulation of the Inflammatory Response, Proliferation, Migration, and Epithelial-Mesenchymal Transition of Human Lens Epithelial Cells by the lncRNA-MALAT1\/miR-26a-5p\/TET1 Signaling Axis","volume":"2023","author":"Hu","year":"2023","journal-title":"J. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2147\/JIR.S338162","article-title":"Novel Insights into the Emerging Role of Neat1 and Its Effects Downstream in the Regulation of Inflammation","volume":"15","author":"Pan","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chi, H.-C., Tsai, C.-Y., Tsai, M.-M., Yeh, C.-T., and Lin, K.-H. (2017). Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18091903"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Gupta, S., Silveira, D.A., Mombach, J.C.M., and Hashimoto, R.F. (2025). DNA Damage-Induced Ferroptosis: A Boolean Model Regulating p53 and Non-Coding RNAs in Drug Resistance. Proteomes, 13.","DOI":"10.3390\/proteomes13010006"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13046-016-0297-z","article-title":"Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107\/CDK6 pathway","volume":"35","author":"Wang","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jds.2021.09.018","article-title":"The relation between NEAT1 expression level and survival rate in patients with oral squamous cell carcinoma","volume":"17","author":"Lin","year":"2022","journal-title":"J. Dent. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e12329","DOI":"10.1111\/cpr.12329","article-title":"NEAT1: A novel cancer-related long non-coding RNA","volume":"50","author":"Yu","year":"2017","journal-title":"Cell Prolif."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.biopha.2018.04.053","article-title":"lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis","volume":"103","author":"Qi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gu, J., Zhang, B., An, R., Qian, W., Han, L., Duan, W., Wang, Z., and Ma, Q. (2022). Molecular Interactions of the Long Noncoding RNA NEAT1 in Cancer. Cancers, 14.","DOI":"10.3390\/cancers14164009"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Shin, J.-J., Park, J., Shin, H.-S., Arab, I., Suk, K., and Lee, W.-H. (2024). Roles of lncRNAs in NF-\u03baB-Mediated Macrophage Inflammation and Their Implications in the Pathogenesis of Human Diseases. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202401.2228.v1"},{"key":"ref_34","unstructured":"U.S. Department of Health and Human Services (2017). Common Terminology Criteria for Adverse Events (CTCAE) v.5.0, Cancer Therapy Evaluation Program; U.S. Department of Health and Human Services."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MCO.0000000000000389","article-title":"Assessing nutritional status in cancer: Role of the Patient-Generated Subjective Global Assessment","volume":"20","author":"Ottery","year":"2017","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","article-title":"Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis","volume":"26","author":"Machtay","year":"2008","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Gkikoudi, A., Kalospyros, S.A., Triantopoulou, S., Logotheti, S., Softa, V., Kappas, C., Theodorou, K., Laiakis, E.C., Manda, G., and Terzoudi, G.I. (2023). Applied sciences Molecular Biomarkers for Predicting Cancer Patient Radiosensitivity and Radiotoxicity in Clinical Practice. Appl. Sci., 13.","DOI":"10.3390\/app132312564"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ncrna.2022.02.004","article-title":"Long noncoding RNAs as promising biomarkers in cancer","volume":"7","author":"Beylerli","year":"2022","journal-title":"Non-coding RNA Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","article-title":"MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside","volume":"15","author":"Ratti","year":"2020","journal-title":"Target. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"55511","DOI":"10.18632\/oncotarget.19224","article-title":"Meta-analysis of microRNAs expression in head and neck cancer: Uncovering association with outcome and mechanisms","volume":"8","author":"Lubov","year":"2017","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"15584","DOI":"10.1007\/s11356-021-12509-5","article-title":"MicroRNA: A novel implication for damage and protection against ionizing radiation","volume":"28","author":"Chen","year":"2021","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2352079","DOI":"10.1155\/2019\/2352079","article-title":"miR-200c Modulates the Pathogenesis of Radiation-Induced Oral Mucositis","volume":"2019","author":"Tao","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1139\/cjpp-2016-0741","article-title":"Implication of microRNAs in the development and potential treatment of radiation-induced heart disease","volume":"95","author":"Kura","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1007\/s13277-015-4227-z","article-title":"The role of MALAT1\/miR-1\/slug axis on radioresistance in nasopharyngeal carcinoma","volume":"37","author":"Jin","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"11733","DOI":"10.1007\/s13277-015-4773-4","article-title":"The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204\/ZEB1 axis in nasopharyngeal carcinoma","volume":"37","author":"Lu","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00405-019-05732-x","article-title":"Blocking long noncoding RNA MALAT1 restrained the development of laryngeal and hypopharyngeal carcinoma","volume":"277","author":"Xu","year":"2020","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"41166","DOI":"10.18632\/oncotarget.17083","article-title":"Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"\u0141asi\u0144ska, I., Kolenda, T., Guglas, K., Kopczy\u0144ska, M., Soboci\u0144ska, J., Teresiak, A., Strzelecki, N.O., Lamperska, K., Mackiewicz, A., and Mackiewicz, J. (2020). Liquid lncRNA Biopsy for the Evaluation of Locally Advanced and Metastatic Squamous Cell Carcinomas of the Head and Neck. J. Pers. Med., 10.","DOI":"10.3390\/jpm10030131"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41419-023-05667-6","article-title":"LncRNA MALAT1 promotes growth and metastasis of head and neck squamous cell carcinoma by repressing VHL through a non-canonical function of EZH2","volume":"14","author":"Duan","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Wang, Y., Guo, Z., Zhao, Y., Jin, Y., An, L., Wu, B., Liu, Z., Chen, X., Chen, X., and Zhou, H. (2017). Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-08890-2"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/aps.2016.164","article-title":"Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer","volume":"38","author":"Gong","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.biopha.2018.03.105","article-title":"Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma","volume":"102","author":"Toraih","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/1759-7714.13450","article-title":"LncRNA HOTAIR enhances breast cancer radioresistance through facilitating HSPA1A expression via sequestering miR-449b-5p","volume":"11","author":"Zhang","year":"2020","journal-title":"Thorac. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/celldisc.2017.2","article-title":"Malat1 regulates myogenic differentiation and muscle regeneration through modulating MyoD transcriptional activity","volume":"3","author":"Chen","year":"2017","journal-title":"Cell Discov."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12986-021-00557-0","article-title":"The long noncoding RNA MALAT1 modulates adipose loss in cancer-associated cachexia by suppressing adipogenesis through PPAR-\u03b3","volume":"18","author":"Han","year":"2021","journal-title":"Nutr. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e23116","DOI":"10.1002\/jcla.23116","article-title":"The implication of LncRNA MALAT1 in promoting chemo-resistance of laryngeal squamous cell carcinoma cells","volume":"34","author":"Jiang","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_57","first-page":"96","article-title":"The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define","volume":"24","author":"Stasiak","year":"2020","journal-title":"Contemp. Oncol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/6\/676\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:50:01Z","timestamp":1760028601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/6\/676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["diagnostics15060676"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15060676","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]}}}